Patent · US Active

Gene fusion

US9777333B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2014
Grant dateOct 3, 2017
Priority date—
Expiry dateApr 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure provides gene fusion variants and novel associations with disease states, as well as kits, probes, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.